Jenny Freeman
Director/Board Member bei SENZIME AB
Vermögen: 184 799 $ am 31.03.2024
Profil
Jenny E.
Freeman was the founder of Respiratory Motion, Inc. (founded in 2010) and JEF Core, Inc. (founded in 2007) where she holds the titles of Director and President respectively.
Dr. Freeman is also the founder of Cheirologic Partners, Inc. Dr. Freeman's current job is as a Director at Senzime AB since 2022.
Dr. Freeman's former jobs include being the President & Chief Executive Officer at HyperMed, Inc., and holding positions as Principal at Sumitomo Pharma America, Inc. and Argose, Inc. Dr. Freeman's education includes an undergraduate degree from Yale University in 1975 and a doctorate degree from New York University in 1979.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SENZIME AB
0,32% | 30.12.2022 | 318 707 ( 0,32% ) | 184 799 $ | 31.03.2024 |
Aktive Positionen von Jenny Freeman
| Unternehmen | Position | Beginn |
|---|---|---|
| SENZIME AB | Director/Board Member | 01.01.2022 |
Respiratory Motion, Inc.
 Respiratory Motion, Inc. Medical SpecialtiesHealth Technology Respiratory Motion, Inc. develops medical devices. The firm specializes in clinical research, clinical evaluation and testing. Its product ExSpiron 1Xi, measures minute ventilation non-invasively. The company was founded by Jenny E. Freeman, Alexander Panasyuk and Svetlana Panasyuk in March 2010 and is headquartered in Waltham, MA. | Chief Executive Officer | 01.03.2010 |
| Cheirologic Partners, Inc. | Founder | - |
Ehemalige bekannte Positionen von Jenny Freeman
| Unternehmen | Position | Ende |
|---|---|---|
JEF Core, Inc.
 JEF Core, Inc. Investment ManagersFinance Headquartered in Weston, Massachusetts, JEF Core, Inc., formerly Cheirologic Partners, Inc. is a research firm covering the health technology sector. | Founder | 01.01.2010 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | - |
| Argose, Inc. | Corporate Officer/Principal | - |
HyperMed, Inc.
 HyperMed, Inc. Medical DistributorsDistribution Services HyperMed, Inc. develops medical imaging devices. The firm provides its services to the vascular surgeons, vascular laboratories, foot and ankle surgeons, podiatrists, research organizations, and educational institutions. The company was founded in 1997 and is headquartered in Burlington, MA. | President | - |
Ausbildung von Jenny Freeman
| Yale University | Undergraduate Degree |
| New York University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SENZIME AB | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Respiratory Motion, Inc.
Respiratory Motion, Inc. Medical SpecialtiesHealth Technology Respiratory Motion, Inc. develops medical devices. The firm specializes in clinical research, clinical evaluation and testing. Its product ExSpiron 1Xi, measures minute ventilation non-invasively. The company was founded by Jenny E. Freeman, Alexander Panasyuk and Svetlana Panasyuk in March 2010 and is headquartered in Waltham, MA. | Health Technology |
JEF Core, Inc.
JEF Core, Inc. Investment ManagersFinance Headquartered in Weston, Massachusetts, JEF Core, Inc., formerly Cheirologic Partners, Inc. is a research firm covering the health technology sector. | Finance |
HyperMed, Inc.
HyperMed, Inc. Medical DistributorsDistribution Services HyperMed, Inc. develops medical imaging devices. The firm provides its services to the vascular surgeons, vascular laboratories, foot and ankle surgeons, podiatrists, research organizations, and educational institutions. The company was founded in 1997 and is headquartered in Burlington, MA. | Distribution Services |
| Argose, Inc. | |
| Cheirologic Partners, Inc. |
